Can discussion of health inequities lead to actionable change?

by Marci A. Landsmann

Policy Matters

Cancer screenings and clinical trials have been seriously disrupted by the pandemic.

by Nicholas Warren, PhD

Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

by Laurie Adami

In her new book, Cancer Support Community executive chair Kim Thiboldeaux offers advice to patients on how to steer their way through a cancer diagnosis, treatment and beyond.

by Kevin McLaughlin

Advances in screening and treatment mean there are more cancer survivors than ever, but survivors who struggle to work can face difficulty getting disability payments.

by Jen Tota McGivney

President Biden resurfaces a proposal for a new health care agency, and the Food and Drug Administration approves a treatment for large B-cell lymphoma.

by Bradley Jones

Attending a scientific conference as a patient advocate can be an exhausting, overwhelming and hugely rewarding experience.

by Bradley Jones

Experts discussed how the cancer community can share accurate information and increase confidence in COVID-19 vaccines, both among people with cancer and the general population.

by Kevin McLaughlin

Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.

by Marci A. Landsmann

Forward Look

Despite efforts by policymakers, a gender gap persists in clinical trial participation.

by Lindsey Konkel